Author
Listed:
- Jimin Min
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
- Paige N. Vega
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
- Amy C. Engevik
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
- Janice A. Williams
(Vanderbilt University School of Medicine)
- Qing Yang
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine
Shandong University)
- Loraine M. Patterson
(University of North Carolina at Chapel Hill)
- Alan J. Simmons
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
- R. Jarrett Bliton
(University of North Carolina at Chapel Hill)
- Joshua W. Betts
(Vanderbilt University School of Medicine)
- Ken S. Lau
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
- Scott T. Magness
(University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill
University of North Carolina Chapel Hill/ North Carolina State University joint Departments of Biomedical Engineering
University of North Carolina at Chapel Hill)
- James R. Goldenring
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine
Vanderbilt University School of Medicine
Nashville VA Medical Center)
- Eunyoung Choi
(Vanderbilt University School of Medicine
Vanderbilt University School of Medicine)
Abstract
Dysplasia is considered a key transition state between pre-cancer and cancer in gastric carcinogenesis. However, the cellular or phenotypic heterogeneity and mechanisms of dysplasia progression have not been elucidated. We have established metaplastic and dysplastic organoid lines, derived from Mist1-Kras(G12D) mouse stomach corpus and studied distinct cellular behaviors and characteristics of metaplastic and dysplastic organoids. We also examined functional roles for Kras activation in dysplasia progression using Selumetinib, a MEK inhibitor, which is a downstream mediator of Kras signaling. Here, we report that dysplastic organoids die or show altered cellular behaviors and diminished aggressive behavior in response to MEK inhibition. However, the organoids surviving after MEK inhibition maintain cellular heterogeneity. Two dysplastic stem cell (DSC) populations are also identified in dysplastic cells, which exhibited different clonogenic potentials. Therefore, Kras activation controls cellular dynamics and progression to dysplasia, and DSCs might contribute to cellular heterogeneity in dysplastic cell lineages.
Suggested Citation
Jimin Min & Paige N. Vega & Amy C. Engevik & Janice A. Williams & Qing Yang & Loraine M. Patterson & Alan J. Simmons & R. Jarrett Bliton & Joshua W. Betts & Ken S. Lau & Scott T. Magness & James R. Go, 2019.
"Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach,"
Nature Communications, Nature, vol. 10(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13479-6
DOI: 10.1038/s41467-019-13479-6
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-13479-6. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.